StonvexLoading…
StonvexStonvexStonvexCore line items from BAM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $990.00M | $3.94B | $2.86B | $1.89B |
Operating Income | $696.00M | $2.92B | $2.01B | $1.24B |
Net Income | $586.00M | $2.40B | $1.78B | $1.09B |
EPS (Diluted) | Not available | Not available | Not available | Not available |
Total Assets | $17.94B | $17.05B | $16.52B | $16.14B |
Total Liabilities | $6.70B | $6.74B | $5.85B | $5.11B |
Cash & Equivalents | $1.04B | $1.58B | $1.06B | $480.00M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | Not available | Not available | Not available | Not available |